fda drug shortages semaglutide injection resolved date 2025 crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many FDA declares semaglutide (Ozempic/Wegovy) shortage

gastric ultrasound study provides the most robust evidence to date, examining 220 patients and finding retained gastric contents in 40% of semaglutide patients versus 3% of controls (adjusted odds ratio 36.97, 95% confidence interval 16.5499.32) [34]

If you see any air bubbles, lightly tap or flick the syringe to draw the bubbles to the top (the end with the needle) and expel the air

Common Side Effects: Nausea, diarrhea, vomiting, constipation Stomach pain, decreased appetite, headache Serious Side Effects (less frequent): Pancreatitis, gallbladder issues Kidney problems, potentially linked to dehydration from side effects Serious allergic reactions, vision changes (especially in type 2 diabetes patients), increased heart rate Oral semaglutide also comes with a boxed warning concerning the risk of thyroid C-cell tumors, based on animal studies, and is unsuited for individuals with a family history of certain thyroid cancers

Using them on your body steps outside that research lane

Adults seeking diet-first GLP-1 support for satiety, appetite, and steady post-meal energy